Journal
Alzheimers Research & Therapy
Publication Date
12-12-2019
Volume
11
Issue
1
First Page
101
Document Type
Open Access Publication
DOI
10.1186/s13195-019-0559-z
Rights and Permissions
Klein, G., Delmar, P., Voyle, N. et al. Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis. Alz Res Therapy 11, 101 (2019). doi.org/10.1186/s13195-019-0559-z This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Recommended Citation
Klein, Gregory; Delmar, Paul; Voyle, Nicola; Rehal, Sunita; Hofmann, Carsten; Abi-Saab, Danielle; Andjelkovic, Mirjana; Ristic, Smiljana; Wang, Guoqiao; Bateman, Randall; Kerchner, Geoffrey A; Baudler, Monika; Fontoura, Paulo; and Doody, Rachelle, "Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: A PET substudy interim analysis." Alzheimers Research & Therapy. 11, 1. 101 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/11895
Tables S1-S2 and Figures S1-S4
